146 related articles for article (PubMed ID: 22845339)
21. Prescriptions for schedule II opioids and benzodiazepines increase after the introduction of computer-generated prescriptions.
McGerald G; Dvorkin R; Levy D; Lovell-Rose S; Sharma A
Acad Emerg Med; 2009 Jun; 16(6):508-12. PubMed ID: 19388914
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of prescribers whose patients shop for opioids: results from a cohort study.
Cepeda MS; Fife D; Berlin JA; Mastrogiovanni G; Yuan Y
J Opioid Manag; 2012; 8(5):285-91. PubMed ID: 23247905
[TBL] [Abstract][Full Text] [Related]
23. Connecticut Prescription Monitoring and Reporting System (CPMRS). How prescribers and pharmacists can help reduce prescription drug misuse and abuse.
Conn Med; 2008 Aug; 72(7):439-40. PubMed ID: 18763674
[No Abstract] [Full Text] [Related]
24. Appropriate prescribing of opiates as professional conduct.
McDonald J
R I Med J (2013); 2013 Nov; 96(11):33-5. PubMed ID: 24187676
[TBL] [Abstract][Full Text] [Related]
25. Trouble getting started: predictors of primary medication nonadherence.
Fischer MA; Choudhry NK; Brill G; Avorn J; Schneeweiss S; Hutchins D; Liberman JN; Brennan TA; Shrank WH
Am J Med; 2011 Nov; 124(11):1081.e9-22. PubMed ID: 22017787
[TBL] [Abstract][Full Text] [Related]
26. Dental screening and referral of young children by pediatric primary care providers.
dela Cruz GG; Rozier RG; Slade G
Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
[TBL] [Abstract][Full Text] [Related]
27. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
Mott DA; Cline RR
Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
[TBL] [Abstract][Full Text] [Related]
28. The comparative effectiveness of 2 electronic prescribing systems.
Kaushal R; Barron Y; Abramson EL
Am J Manag Care; 2011 Dec; 17(12 Spec No.):SP88-94. PubMed ID: 22216773
[TBL] [Abstract][Full Text] [Related]
29. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.
Tamblyn R; Huang A; Perreault R; Jacques A; Roy D; Hanley J; McLeod P; Laprise R
CMAJ; 2003 Sep; 169(6):549-56. PubMed ID: 12975221
[TBL] [Abstract][Full Text] [Related]
30. Community forum seeks ways to quell overdose epidemic in RI: less than 20 percent of physicians use prescription monitoring database.
Korr M
R I Med J (2013); 2014 Mar; 97(3):62-3. PubMed ID: 24960858
[No Abstract] [Full Text] [Related]
31. The use of prescription monitoring programs to reduce opioid diversion and improve patient safety.
Morgan L; Weaver M; Sayeed Z; Orr R
J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):4-9. PubMed ID: 23190160
[TBL] [Abstract][Full Text] [Related]
32. Prescription Monitoring Program Trends Among Individuals Arrested in Maine for Trafficking Prescription Drugs in 2014.
McCall K; Nichols SD; Holt C; Ochs L; Cattabriga G; Tu C
Pharmacotherapy; 2016 Jun; 36(6):585-9. PubMed ID: 27087386
[TBL] [Abstract][Full Text] [Related]
33. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
[TBL] [Abstract][Full Text] [Related]
34. Opioid shopping behavior: how often, how soon, which drugs, and what payment method.
Cepeda MS; Fife D; Chow W; Mastrogiovanni G; Henderson SC
J Clin Pharmacol; 2013 Jan; 53(1):112-7. PubMed ID: 23400751
[TBL] [Abstract][Full Text] [Related]
35. Primary care physicians' dementia care practices: evidence of geographic variation.
Fortinsky RH; Zlateva I; Delaney C; Kleppinger A
Gerontologist; 2010 Apr; 50(2):179-91. PubMed ID: 19597058
[TBL] [Abstract][Full Text] [Related]
36. Potential determinants of prescribers' drug-drug interaction knowledge.
Ko Y; Malone DC; D'Agostino JV; Skrepnek GH; Armstrong EP; Brown M; Woosley RL
Res Social Adm Pharm; 2008 Dec; 4(4):355-66. PubMed ID: 19064242
[TBL] [Abstract][Full Text] [Related]
37. Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts.
Thomas CP; Kim M; Nikitin RV; Kreiner P; Clark TW; Carrow GM
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):950-7. PubMed ID: 24920376
[TBL] [Abstract][Full Text] [Related]
38. Impact of prescription drug-monitoring program on controlled substance prescribing in the ED.
McAllister MW; Aaronson P; Spillane J; Schreiber M; Baroso G; Kraemer D; Smotherman C; Gray-Eurom K
Am J Emerg Med; 2015 Jun; 33(6):781-5. PubMed ID: 25842283
[TBL] [Abstract][Full Text] [Related]
39. Using the Rhode Island Prescription Drug Monitoring Program (PMP).
McDonald JV
R I Med J (2013); 2014 Jun; 97(6):64-5. PubMed ID: 24905380
[No Abstract] [Full Text] [Related]
40. Direct observation of requests for clinical services in office practice: what do patients want and do they get it?
Kravitz RL; Bell RA; Azari R; Kelly-Reif S; Krupat E; Thom DH
Arch Intern Med; 2003 Jul; 163(14):1673-81. PubMed ID: 12885682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
